Compliance Rate

Compliance Rate 100.0%
Compliant submissions 1
Incompliant submissions 0
Total trials 1

My Organizations' Clinical Trials

Showing 850 of 3173 entries
View as:

A Study to Assess Pharmacokinetics of PF-04965842 and Its Metabolites and Effect of Probenecid in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT03937258 Org: User:
Start: 05/21/19 End: 07/26/19 Due: 07/26/20

Safety and Efficacy of Celecoxib Versus Diclofenac in the Treatment of Ankylosing Spondylitis

Phase: N/A Priority: Normal
NCT ID: NCT00648141 Org: User:
Start: 01/31/03 End: 01/31/05 Due: 01/31/06

Efficacy And Safety Of Parecoxib 40mg vs. Ketoprofen 100mg In The Management Of Acute Renal Colic

Phase: N/A Priority: Normal
NCT ID: NCT00553605 Org: User:
Start: 06/30/07 End: 06/30/09 Due: 06/30/10

Effects Of CP-690,550 (Tasocitinib) On Cholesterol Metabolism In Patients With Active Rheumatoid Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT01262118 Org: User:
Start: 05/31/11 End: 02/29/12 Due: 02/28/13

Vfend Special Investigation For Pediatric - Observational

Phase: N/A Priority: Normal
NCT ID: NCT02554656 Org: User:
Start: 10/27/15 End: 09/25/18 Due: 09/25/19

Multiple Oral Doses Of PH-797804 In Healthy Japanese Adult Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01217918 Org: User:
Start: 10/31/10 End: 02/28/11 Due: 02/28/12

Study To Assess The Impact Of Hepatic Impairment On The Safety, Tolerability And Pharmacokinetics Of Single-Dose 200 Mg Of PF-868554

Phase: N/A Priority: Normal
NCT ID: NCT00651027 Org: User:
Start: 02/29/08 End: 09/30/08 Due: 09/30/09

Abrocitinib Expanded Access Protocol in Adolescents and Adults With Moderate to Severe Atopic Dermatitis

Phase: N/A Priority: Normal
NCT ID: NCT04564755 Org: User:
Start: - End: - Due: -

Multiple Dose Escalation Study In Medically Stable Subjects With Psoriasis

Phase: N/A Priority: Normal
NCT ID: NCT01736696 Org: User:
Start: 11/30/02 End: 04/30/04 Due: 04/30/05

Dalteparin vs Unfractionated Heparin For The Prevention Of Venous Thromboembolism (VTE) In Hospitalized Acutely Ill Medical Patients

Phase: N/A Priority: Normal
NCT ID: NCT00445328 Org: User:
Start: 06/30/07 End: 07/31/08 Due: 07/31/09

A Study to Evaluate the Efficacy and Safety of Two Doses of PF-03654746 in Adults With Attention Deficit Hyperactivity Disorder (ADHD).

Phase: N/A Priority: Normal
NCT ID: NCT00531752 Org: User:
Start: 12/31/07 End: 09/30/08 Due: 09/30/09

Adjuvant Epirubicin/Cytoxan Followed By A Taxane VS. Epirubicin/Taxane As Treatment For Node-Positive Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00140075 Org: User:
Start: 11/30/00 End: 08/31/06 Due: 08/31/07

A Study To Investigate The Safety, Toleration And Efficacy of PF00610355 In Chronic Obstructive Pulmonary Disease (COPD) Patients.

Phase: N/A Priority: Normal
NCT ID: NCT00808288 Org: User:
Start: 03/31/10 End: 12/31/10 Due: 12/31/11

Evaluate Long-Term Safety and Efficacy of Pregabalin in Patients With Chronic Neuropathic Pain.

Phase: N/A Priority: Normal
NCT ID: NCT00141362 Org: User:
Start: 10/31/01 End: 08/31/05 Due: 08/31/06

Understanding Hemophilia A and B Drug Dosage Administration Patterns

Phase: N/A Priority: Normal
NCT ID: NCT03248141 Org: User:
Start: 09/01/17 End: 03/14/18 Due: 03/14/19

Effect of Multiple Doses of Modafinil on the Pharmacokinetics of Single Dose Lorlatinib in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT03961997 Org: User:
Start: 08/22/19 End: 12/09/19 Due: 12/09/20

A Drug Drug Interaction Study Between PF-06826647 And Oral Contraceptive Steroids In Healthy Female Participants

Phase: N/A Priority: Normal
NCT ID: NCT04134715 Org: User:
Start: 10/23/19 End: 01/09/20 Due: 01/09/21

Prinomastat Plus Temozolomide Following Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme

Phase: N/A Priority: Normal
NCT ID: NCT00004200 Org: User:
Start: 10/31/99 End: - Due: -

Study Evaluating Safety and Immunogenicity of 13-Valent Pneumococcal Conjugate Vaccine With Influenza Vaccine in Adults

Phase: N/A Priority: Normal
NCT ID: NCT00492557 Org: User:
Start: 09/30/07 End: 02/29/08 Due: 02/28/09

A Phase I, Multiple Dose Study of PF-04447943 in Healthy Elderly Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT00736528 Org: User:
Start: 08/31/08 End: 09/30/08 Due: 09/30/09

A Study To Evaluate The Safety And Efficacy Of PF-06826647 In Participants With Moderate To Severe Ulcerative Colitis

Phase: N/A Priority: Normal
NCT ID: NCT04209556 Org: User:
Start: 09/30/20 End: 10/26/23 Due: 10/26/24

A Study of HR+/HER2- Metastatic Breast Cancer Patients Treated With Palbociclib Together With an Aromatase Inhibitor From 2017 to 2023 in Denmark.

Phase: N/A Priority: Normal
NCT ID: NCT06307457 Org: User:
Start: 03/11/24 End: 04/19/24 Due: 04/19/25

Study Evaluating A Novel Ibuprofen Formulation In The Treatment Of Dental Pain

Phase: N/A Priority: Normal
NCT ID: NCT01098747 Org: User:
Start: 04/30/10 End: 08/31/10 Due: 08/31/11

A Study To Investigate The Effect Of Erythromycin On The Pharmacokinetics Of PH-797804

Phase: N/A Priority: Normal
NCT ID: NCT01589614 Org: User:
Start: 06/30/12 End: 08/31/12 Due: 08/31/13

Safety and Immunogenicity of Pneumococcal Conjugate Formulations in Healthy Adults 18 Through 49 Years of Age

Phase: N/A Priority: Normal
NCT ID: NCT05489328 Org: User:
Start: 08/15/22 End: 10/07/22 Due: 10/07/23